Biotech Values

[DewDiligence]

Macugen phase-3 data:
Correction to #648:

The row descriptors in the third and fourth rows of the table in message #648 are incorrect: the third-row header should be “>-3” (rather than >=-3) and the fourth-row header should be “>-6” (rather than >=-6). A corrected version of the table is as follows:

 
 Change in lines 
 visual acuity        % of Patients 
 at 1 year         MACUGEN    PLACEBO 
                              
 >=+3 (“improved”)    6          2 
 >= 0                33         23 
 > -3 (“stable”)     70         55 
 > -6                90         78